Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

Summary Background Early intensive insulin therapy in patients with newly diagnosed type 2 diabetes might improve β-cell function and result in extended glycaemic remissions. We did a multicentre, randomised trial to compare the effects of transient intensive insulin therapy (continuous subcutaneous...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2008-05, Vol.371 (9626), p.1753-1760
Hauptverfasser:	Weng, Jianping, Prof, Li, Yanbing, Prof, Xu, Wen, MD, Shi, Lixin, Prof, Zhang, Qiao, MD, Zhu, Dalong, Prof, Hu, Yun, MD, Zhou, Zhiguang, Prof, Yan, Xiang, MD, Tian, Haoming, Prof, Ran, Xingwu, MD, Luo, Zuojie, Prof, Xian, Jing, MD, Yan, Li, Prof, Li, Fangping, MD, Zeng, Longyi, MD, Chen, Yanming, MD, Yang, Liyong, Prof, Yan, Sunjie, MD, Liu, Juan, MD, Li, Ming, MD, Fu, Zuzhi, Prof, Cheng, Hua, Prof
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Blood Glucose - drug effects Diabetes Mellitus, Type 2 - drug therapy Female Glycated Hemoglobin A - drug effects Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use Infusions, Intravenous Injections, Intravenous Insulin - administration & dosage Insulin - pharmacology Insulin - therapeutic use Insulin-Secreting Cells - drug effects Insulin-Secreting Cells - metabolism Internal Medicine Male Middle Aged Remission Induction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!